Your session is about to expire
← Back to Search
COVID-19 Testing Methods for Coronavirus
Study Summary
This trial will test different ways of testing for COVID-19 in 1,386 households in Baltimore City to find the best method.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a child aged 12 or older and agree to participate.The person's primary residence is in the household that is being sampled.Someone in my home can mentally handle completing a survey.Someone in my home over 18 speaks English or Spanish.Someone in my household over 18 speaks English or Spanish.I am not mentally able to complete a survey.I am 12 years or older and agree to participate.and Baltimore County to purchase a single-family homeRequirements for families to participate in the study.for all studies
At least one person in the household agrees to all studies that are conducted in their home.Requirements for people who can participate in the study.
- Group 1: Fixed site SOC testing
- Group 2: Community-based testing
- Group 3: Self-collected testing
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this experiment still open to participants?
"It appears that the research posted on clinicaltrials.gov is no longer recruiting patients, as it was first listed in February 8th 2021 but last updated December 7th 2021. Nevertheless, there are still 91 other studies open for recruitment at this time."
What is the anticipated result of this experiment?
"This medical research has the primary objective of determining uptake rates regarding SARS-CoV-2 testing within a 30 day period post randomization. Secondary endpoints include: time to completion of testing, amount of time needed for results from tests to be received by participants, and uptake rate concerning SARS CoV-2 testing in relation to those randomly chosen for this study."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger